Increased Options for COVID-19 Testing: Curative Product Offerings
5 Minutes
Team Curative
Dec 15, 2021
Curative now offers more testing solutions as we continue to battle the COVID-19 pandemic. When booking an appointment for a COVID-19 test, it is important to know what options are available and which test to select. Here’s a break down of our product offerings so you can make an informed decision when booking your upcoming test:
RT- PCR Tests for COVID-19
Curative HT SARS-CoV-2 Test* (Laboratory-Developed Test; EUA application under review by FDA)
Abbott Alinity m SARS-CoV-2**
FDA Emergency Use Authorization
Test results are confidential and delivered digitally, typically within 1-2 days after arrival at the lab
Specimen collection is self-collected under the direction and observation of a healthcare worker
A standard, lab based PCR test is a diagnostic nucleic acid amplification test (NAAT) that can tell you if you have a current infection. A NAAT is a type of viral diagnostic test for SARS-CoV-2, the virus that causes COVID-19. NAATs detect genetic material (nucleic acids) and specifically identify the RNA (ribonucleic acid) sequences that comprise the genetic makeup of the virus.
NAAT works by amplifying the virus’s genetic material, if any is present in a specimen. According to the CDC, NAATs can detect small amounts of SARS-CoV-2 and are unlikely to return a false-negative result.
Abbott ID NOW test for COVID-19**
FDA Emergency Use Authorization
Rapid molecular test for SARS-CoV-2
Self-collected, anterior nasal swab
Specimen collection is observed and directed by a healthcare worker
Results delivered digitally to the patient, typically within 2 hours
While polymerase chain reaction (PCR) tests are molecular tests, not all molecular tests use PCR methodology. Molecular tests that are not PCR have a similarly high sensitivity rate compared to antigen tests. Molecular tests detect genetic material – the RNA – of the coronavirus and are sensitive enough to need only a very tiny amount of it. It is useful when same-day molecular results are needed or when a patient is symptomatic or exposed to COVID-19.
Laboratory-based NAATs are considered the most sensitive tests by the CDC for detecting SARS-CoV-2, but also the longest to produce results. Results from Curative are delivered in 1-2 days. A lab PCR test can help to validate your results if you’ve taken a less sensitive test.
~2 Hour RT-PCR Test for COVID-19
FDA Emergency Use Authorization
Available for symptomatic or asymptomatic patients
Test results are typically available same day
Specimen collection is self-collected under the direction and observation of a healthcare worker
This test is generally accepted anywhere a PCR test is required, check your organization’s requirements carefully
Rapid PCR results are typically available within an hour. These tests are offered as point-of-care and self-administered tests, which mean they are more accessible, especially outside of a healthcare setting. The level of sensitivity for the detection of SARS-CoV-2 genetic material in a specimen varies depending on the type of NAAT. Rapid PCR tests are generally accepted in circumstances where a PCR test result is required; check your organization’s requirements carefully.
~1 Hour Rapid Antigen test for SARS-CoV-2
Abbott BinaxNOW COVID-19 Ag Card**
FDA Emergency Use Authorization
Specimen collection is a shallow nasal swab administered by a healthcare worker
Test results are delivered delivered digitally, typically within 1 hour
Rapid antigen tests usually detect the presence of a specific viral antigen, which means the person has a current viral infection. Currently, rapid antigen tests are emergency use authorized for point-of-care, lab, and self-administered testing. Curative offers rapid antigen tests that return results typically within 1 hour, but sensitivity is less than that of NAATs. According to the CDC, antigen tests perform best amongst symptomatic people. If symptomatic and receiving a negative rapid antigen test, it is still important to maintain social distancing and isolation until a Lab PCR can be performed.
————
At Curative, we’re pleased to offer these products to tackle the pandemic in a way that is most convenient and appropriate to the patient. When making an appointment at Curative.com, patients can see which tests are offered at each location and choose their site accordingly. If you have further questions on which test is most appropriate, please contact your healthcare provider.
Antigen Tests: **For more information about the performance & intended use of the Abbot BinaxNOW COVID-19 Ag Card, please see the following EUA, patient fact sheet, & provider fact sheet.
Abbott Alinity m PCR Tests: **For more information about the performance & intended use, please see the following EUA, patient fact sheet, provider fact sheet,
Accula SARS-CoV-2 Test: **For more information about the performance & intended use, please see the following EUA, patient fact sheet, provider fact sheet.
Abbott ID NOW Test: **For more information about the performance & intended use of the Abbott ID Now COVID-19 molecular test please see the following EUA, IFU, patient fact sheet, provider fact sheet
*Validated laboratory developed test (LDT) that has not been FDA approved or cleared.
**These tests have not been FDA cleared or approved, but have been authorized for emergency use by FDA (EUA). These tests have been authorized only for the detection of SARS-CoV-2, not for any other viruses or pathogens.
The emergency use of these tests is only authorized for the duration of the emergency declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
Sign up for our Newsletter
Popular Articles
Fueling Your Wellness Journey: Tips for a Balanced Diet from H-E-B Dietitians
MAR 18, 2024
Navigating Heart Health in Florida: Why the Best Health Insurance Companies Focus on Preventive Care
MAR 8, 2024
The Importance of a Cancer Screening Test: A Key Strategy in Prevention and Early Detection
FEB 26, 2024
Follow Us
